Wei Cui

机构：Shanxi Medical University, Zhejiang Cancer Hospital, Hangzhou Cancer Hospital · ORCID：0009-0009-1046-4910

发表论文 19 篇 · 总被引 254 次 · h-index 7

代表论文

• LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer (2021 · Nature Cancer · 被引 60)
• Suppression of NF-κB Signaling and P-glycoprotein Function by Gambogic Acid Synergistically Potentiates Adriamycin -induced Apoptosis in Lung Cancer (2014 · Current Cancer Drug Targets · 被引 49)
• In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors (2017 · Drug Design Development and Therapy · 被引 40)
• Ultrasound-targeted microbubble destruction mediated miR-492 inhibitor suppresses the tumorigenesis in non-small cell lung cancer (2021 · Annals of Medicine · 被引 33)
• Cross talk between oxidative stress and hypoxia via thioredoxin and HIF‐2α drives metastasis of hepatocellular carcinoma (2020 · The FASEB Journal · 被引 27)
• Hypoxia induces calpain activity and degrades SMAD2 to attenuate TGFβ signaling in macrophages (2015 · Cell & Bioscience · 被引 19)